30-Day Mortality in Myocardial Infarction Patients
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
The proportion of patients with acute coronary syndrome (ACS) who have died within 30 days of the ACS diagnosis.
Numerator
Patients with acute coronary syndrome (ACS) who have died within 30 days of the ACS diagnosis
Denominator
All patients in hospital treatment due to ACS during the period in question or those who died due to causes associated with ACS who were not in hospital due to ACS during the 365 days prior to the date of death or hospital treatment
Exclusions
Patients under 18 years of age, long-term patients, and patients whose home municipality is unknown or located abroad or on the Åland Islands according to the care notification.
Use of Risk Adjustment
Risk Adjustments
Age, gender and associated diseases as well as hospital transfer and the number of treatment days in inpatient care during the 365 days preceding the start of monitoring
Stratifications
Region, the well-being services county, hospital district, whole country
Data Attributes
Type of Data Collection
Data Collection Methods
PERFECT - PERFormance, Effectiveness and Cost of Treatment episodes (THL) The research data are based on the following registers: THL: Hospital discharge registers, Finnish Care Register (incl. data in supplements on cerebral infarction patients), Register of primary health care visits, Endoprosthesis register Social Insurance Institution: entitlements to special refunds on medicine (free-of-charge), medicine reimbursements, private examinations and treatments, visits to private practitioners Statistics Finland: Causes of Death Register Digital and population data services agency, Population information system: date of death and marital status
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reported on website. To reduce variation caused by randomness, the numbers are presented for two-year cohorts.